Chinese products submitted for regulatory approval in EU will require pre-clinical and/or clinical data to be generated under the supervision of an approved Clinical Research Organisation (CRO).

Stravencon identifies the most appropriate EU regulatory pathway including approved clinical centres and research organisations.